C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.

Vanessa F Bonazzi,Lauren G Aoude,Sandra Brosda,Julia J Bradford,James M Lonie,Kelly A Loffler,Michael G Gartside,Kalpana Patel,Pamela Mukhopadhyay,Colm Keane,Val Gebski,James G Kench,David Goldstein,Nicola Waddell,Andrew P Barbour

Asia-Pacific journal of clinical oncology（2023）

引用 0|浏览33

暂无评分

摘要

PDAC patients with long survival have higher hENT1 expression levels. Furthermore, CRP expression is a biomarker of poor prognosis following perioperative chemotherapy and resection in PDAC patients and thus may be useful for identifying patients who could benefit from more aggressive adjuvant strategies.

查看译文

关键词

biomarker, C-reactive protein, pancreatic adenocarcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要